临床试验/JPRN-jRCT2080221351

JPRN-jRCT2080221351未知3 期

TK-641 Phase 3 Study

TEIKOKU SEIYAKU CO., LTD.0 个研究点开始时间: 2011年1月14日最近更新: 2023年10月17日

试验速览

阶段: 3 期
发起方: TEIKOKU SEIYAKU CO., LTD.

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: >= 20age old 至 <= 74age old（—）
性别: All

入选标准

•1) Cancer patients who can be hospitalized for clinical trial
•2) Patients who are 20-74 years old at the time of informed consent
•3) Patients who have been received cancer pain therapy with opioid

排除标准

•1) Patients who have any complications or history of cardiac conduction disturbance
•2) Patients who have any complications or history of abnormality of respiratory function
•3) Patients with any organic encephalopathies

研究者

发起方

TEIKOKU SEIYAKU CO., LTD.

相似试验

TK-642 Phase 2 Study

JPRN-jRCT2080221268TEIKOKU SEIYAKU CO., LTD.

KD-357 Phase III Studypreexposure prophylaxis against rabies

JPRN-jRCT2080222145The Chemo-Sero-Therapeutic Research Institute200

KD-357 Phase II/III Studypreexposure prophylaxis against rabies

JPRN-jRCT2080222295The Chemo-Sero-Therapeutic Research Institute30

K-755 Phase 1 studyhealthy males

JPRN-jRCT2080224071Kowa Co., Ltd.78

Phase 3 Study of SK-1403Secondary Hyperparathyroidism Receiving Hemodialysis

JPRN-jRCT2080224528Sanwa Kagaku Kenkyusho Co., Ltd.150